Stay updated on Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.7%
    Check dated 2025-03-25T20:20:32.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-03-18T14:56:19.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-03-11T09:22:25.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2025-03-04T05:41:43.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated to reflect new study results and objectives related to the administration of nivolumab and ABI-009 in various advanced cancers, with specific details on dosing, patient eligibility, and study timelines. Additionally, the results reporting dates have been revised to include future dates for expected results.
    Difference
    15%
    Check dated 2025-02-24T23:24:53.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-02-17T19:53:50.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.